Unique ID issued by UMIN | UMIN000003428 |
---|---|
Receipt number | R000004151 |
Scientific Title | A feasibility study of neoadjuvant chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer |
Date of disclosure of the study information | 2010/04/01 |
Last modified on | 2014/06/04 18:53:31 |
A feasibility study of neoadjuvant
chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer
A feasibility study of neoadjuvant
chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer
A feasibility study of neoadjuvant
chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer
A feasibility study of neoadjuvant
chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer
Japan |
rectal cancer
Gastrointestinal surgery |
Malignancy
NO
The purpose of this study was to establish the feasibility, efficacy, and survival rate of preoperative chemotherapy with mFOLFOX6 in patients with locally metastatic rectal cancer.
Safety,Efficacy
OS, DFS
Pathological effect, Down stgaging
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Neoadjuvant chemotherapy with mFOLFOX6(4-6cycle) followed by surgery
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1.Histologically confirmed Rectum adenocarcinoma
2.No prior anti-tumor therapy without surgery
3.More than 4 weeks interval after surgery
4.Synchronous or metachronous liver metastases(H2,H3)
5. Performance status 0-2
6. age:20-75years old
7. A predicted life expectancy of at least 12 weeks
8. Adequate organ function
9.Written IC
1.Transfusion, blood products, and G-CSF within 14 days before egistration
2.History of serious drug hypersensitivity or allergy
3.Multiple malignancies
4.Uncontrolled complication of pleural, ascites and pericardium fluid
5.Infection
6 Current or previous brain and bone
metastasis
7.Serious heart disease such as congestive heart failure, symptomatic coronary artery disease, uncontrolled arrhythmia
8.Serious hepatic toxicit, pulmonary complaints(interstitial pneumonia)
9.Serious dysesthesia
10.Diarrhea
11.Intestinal paralysis and intestinal obstruction
12.Evidence of psychiatric disability interfering with enrollment to clinical trial
13.Uncontrolled diabetic
14.With atazanavir sulfate.
15.With TS-1
16.Pregnancy
17.Patients judged inappropriate for this study by physicians
20
1st name | |
Middle name | |
Last name | Junichi Koike |
Toho University school of medicine
Division of general and gastroenterological surgery, Department of Surgery (Omori)
6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541. Japan
03-3762-4151
jkoike18@med.toho-u.ac.jp
1st name | |
Middle name | |
Last name | Junichi Koike |
Toho University school of medicine
Division of general and gastroenterological surgery, Department of Surgery (Omori)
6-11-1 Omori-Nishi, Ota-ku, Tokyo 143-8541. Japan
03-3762-4151
jkoike18@med.toho-u.ac.jp
Toho University school of medicine
Toho University school of medicine
Self funding
NO
2010 | Year | 04 | Month | 01 | Day |
Unpublished
Open public recruiting
2010 | Year | 01 | Month | 13 | Day |
2010 | Year | 04 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
2014 | Year | 06 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004151